Literature DB >> 25699412

Characterization of radiation-induced cavernous malformations and comparison with a nonradiation cavernous malformation cohort.

Jeremy K Cutsforth-Gregory1, Giuseppe Lanzino, Michael J Link, Robert D Brown, Kelly D Flemming.   

Abstract

OBJECT: The objective of this study was to characterize the clinical features of radiation-induced cavernous malformations (RICMs).
METHODS: The authors retrospectively reviewed the clinical and radiological characteristics of patients with RICMs. The features of these RICMs were then compared with features of nonradiation cavernous malformations (CMs) in 270 patients.
RESULTS: Thirty-two patients with RICMs were identified (56.2% men), with a median age of 31.1 years at RICM diagnosis. The median latency from radiation treatment to RICM diagnosis was 12.0 years (interquartile range 5.0-19.6 years). RICMs were always within the previous radiation port. RICMs were symptomatic at diagnosis in 46.9%, and were associated with symptomatic intracranial hemorrhage at any time in 43.8%. Older age at the time of radiation treatment and higher radiation dose were associated with shorter latency. RICMs tended to be diagnosed at a younger age than nonradiation CMs (median 31.1 vs 42.4 years, respectively; p = 0.054) but were significantly less likely to be symptomatic at the time of diagnosis (46.9% vs 65.8%, respectively; p = 0.036). RICMs were more likely to be multiple CMs than nonradiation CMs (p = 0.0002). Prospectively, the risk of symptomatic hemorrhage was 4.2% for RICMs and 2.3% for nonradiation CMs per person-year (p = 0.556). In the absence of symptoms at presentation, the risk of hemorrhage for RICMs was higher than for nonradiation CMs (4.2% vs 0.35%, respectively; p = 0.118).
CONCLUSIONS: In this patient population, RICMs occurred within the radiation port approximately 12 years after radiation treatment. Compared with nonradiation CMs, RICMs were more likely to occur as multiple CMs, to present at a younger age, and were at least as likely to cause symptomatic hemorrhage.

Entities:  

Keywords:  CM = cavernous malformation; GRE = gradient echo; RICM = radiation-induced CM; RIT = radiation-induced telangiectasia; SWI = susceptibility-weighted imaging; cavernous angioma; cavernous malformation; hemorrhage; mRS = modified Rankin Scale; radiation; vascular disorders

Mesh:

Year:  2015        PMID: 25699412     DOI: 10.3171/2015.1.JNS141452

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  25 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

2.  Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy.

Authors:  Augustin Lecler; Frédérique Charbonneau; Dimitri Psimaras; Marie-Astrid Metten; Antoine Gueguen; Khe Hoang Xuan; Loic Feuvret; Julien Savatovsky
Journal:  Eur Radiol       Date:  2018-04-12       Impact factor: 5.315

3.  Detection of cavernous malformations after whole-brain radiotherapy in primitive neuroectodermal tumor patients-comparing susceptibility-weighted imaging and T2 gradient-echo sequences.

Authors:  Vadim Khasminsky; Michal Yalon; Gahl Greenberg; Galia Tsarfaty; Eli Atar; Chen Hoffmann
Journal:  Neuroradiology       Date:  2018-07-20       Impact factor: 2.804

4.  Novel loss of function mutation in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.

Authors:  Alexandra Russo; Marie Astrid Neu; Johanna Theruvath; Bettina Kron; Arthur Wingerter; Silla Hey-Koch; Yasemin Tanyildizi; Joerg Faber
Journal:  Childs Nerv Syst       Date:  2017-05-09       Impact factor: 1.475

5.  Non-Human Primates Receiving High-Dose Total-Body Irradiation are at Risk of Developing Cerebrovascular Injury Years Postirradiation.

Authors:  Rachel N Andrews; Ethan G Bloomer; John D Olson; David B Hanbury; Gregory O Dugan; Christopher T Whitlow; J Mark Cline
Journal:  Radiat Res       Date:  2020-09-16       Impact factor: 2.841

Review 6.  Clinical Management of Cavernous Malformations.

Authors:  Kelly D Flemming
Journal:  Curr Cardiol Rep       Date:  2017-10-18       Impact factor: 2.931

7.  Biomarkers of cavernous angioma with symptomatic hemorrhage.

Authors:  Seán B Lyne; Romuald Girard; Janne Koskimäki; Hussein A Zeineddine; Dongdong Zhang; Ying Cao; Yan Li; Agnieszka Stadnik; Thomas Moore; Rhonda Lightle; Changbin Shi; Robert Shenkar; Julián Carrión-Penagos; Sean P Polster; Sharbel Romanos; Amy Akers; Miguel Lopez-Ramirez; Kevin J Whitehead; Mark L Kahn; Mark H Ginsberg; Douglas A Marchuk; Issam A Awad
Journal:  JCI Insight       Date:  2019-06-20

8.  Secondary brain tumors after cranial radiation therapy: A single-institution study.

Authors:  Masazumi Fujii; Masahiro Ichikawa; Kensho Iwatate; Mudathir Bakhit; Masayuki Yamada; Yosuke Kuromi; Taku Sato; Jun Sakuma; Hisashi Sato; Atsushi Kikuta; Yoshiyuki Suzuki; Kiyoshi Saito
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-30

Review 9.  Cerebral vascular malformations and their imaging modalities.

Authors:  Atif Zafar; Brian Fiani; Hamid Hadi; Mohammad Arshad; Alessandra Cathel; Muhammad Naeem; Matthew S Parsons; Mudassir Farooqui; Abigail A Bucklin; Michael J Leone; Aqsa Baig; Syed A Quadri
Journal:  Neurol Sci       Date:  2020-04-25       Impact factor: 3.307

10.  Acute and chronic hemorrhage from radiation-induced cavernous malformation associated with late-delayed radiation necrosis in long surviving glioma patients: A case report.

Authors:  Tomoya Oishi; Tomohiro Yamasaki; Satoshi Baba; Shinichiro Koizumi; Tetsuro Sameshima; Hiroki Namba
Journal:  Oncol Lett       Date:  2019-11-19       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.